Skip to main navigation
Skip to search
Skip to main content
Ulster University Home
Home
Researchers
Research units
Projects
Research output
Student theses
Datasets
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Alpha-cells and therapy of diabetes: inhibition, antagonism or death?
Natalie Klempel
, Keith Thomas
,
JM Conlon
,
PR Flatt
,
Nigel Irwin
School of Health Sciences
Faculty Of Life & Health Sciences
School of Biomedical Sciences
Biomedical Sciences Research
Centre for Diabetes
School of Pharm. & Pharmaceut. Sc.
Research output
:
Contribution to journal
›
Article
›
peer-review
6
Citations (Scopus)
95
Downloads (Pure)
Overview
Fingerprint
Student theses
(1)
Fingerprint
Dive into the research topics of 'Alpha-cells and therapy of diabetes: inhibition, antagonism or death?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Adverse Effect
40%
Antidiabetic Agent
40%
Beta Cell
20%
Cell Transdifferentiation
20%
Diabetes
100%
Dipeptidyl Peptidase-4 Inhibitor
20%
Glucagon
60%
Glucagon Like Peptide 1
20%
Glucagon Receptor
40%
Glucagon Receptor Antagonist
20%
Glucagon Release
40%
Gluconeogenesis
20%
Glycon
20%
Hyperglucagonemia
40%
Hyperglycemia
20%
Maturity Onset Diabetes of the Young
20%
Sulfonylurea
20%
Biochemistry, Genetics and Molecular Biology
Animal Model
33%
Cell Ablation
33%
Glucagon
100%
Glucagon Receptor
100%
Glucagon Release
66%
Glucagon-Like Peptide-1
33%
Gluconeogenesis
33%
Hyperglycemia
33%
Receptor Antagonist
33%
Sulfonylurea
33%
Transdifferentiation
33%